Evidence map›Paper›PMID 33649421›Full record

ArticleScientific reports2021

Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors.

Philippe Thuillier, David Bourhis, Jean Philippe Metges, Romain Le Pennec, Karim Amrane, Ulrike Schick, Frédérique Blanc-Beguin, Simon Hennebicq, Pierre-Yves Salaun, Véronique Kerlan and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Correlations between [Cancers · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Philippe ThuillierDepartment of Endocrinology, University Hospital of Brest, Boulevard Tanguy Prigent, 29609, Brest cedex, France. philippe.thuillier@chu-brest.fr.
David BourhisEA GETBO 3878, University Hospital of Brest, Brest, France.
Jean Philippe MetgesDepartment of Oncology, University Hospital of Brest, Brest, France.
Romain Le PennecEA GETBO 3878, University Hospital of Brest, Brest, France.
Karim AmraneDepartment of Radiotherapy, University Hospital of Brest, Brest, France.
Ulrike SchickDepartment of Radiotherapy, University Hospital of Brest, Brest, France.
Frédérique Blanc-BeguinEA GETBO 3878, University Hospital of Brest, Brest, France.
Simon HennebicqEA GETBO 3878, University Hospital of Brest, Brest, France.
Pierre-Yves SalaunEA GETBO 3878, University Hospital of Brest, Brest, France.
Véronique KerlanDepartment of Endocrinology, University Hospital of Brest, Boulevard Tanguy Prigent, 29609, Brest cedex, France.
Nicolas KarakatsanisDepartment of Radiology, Weil Cornell Medical College of Cornell University, New York, NY, USA.
Ronan AbgralEA GETBO 3878, University Hospital of Brest, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To present the feasibility of a dynamic whole-body (DWB)

Indexed as

AdultAgedFemaleHumansMaleMiddle AgedNeuroendocrine TumorsOctreotideOrganometallic CompoundsPositron Emission Tomography Computed TomographyRadionuclide ImagingSpleenTomography, X-Ray ComputedGa(III)-DOTATOCOctreotideOrganometallic Compounds

Identifiers

PMID33649421
PMCPMC7921579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.